铁亡:细胞死亡的机制,在癌症治疗中具有潜在的范围
Mukherjee Bipasha1, Vidhate Deepali1, Deb Prabal2
1Department of Biochemistry, Dr DY Patil Medical College, Navi Mumbai, India.
Asia-Pacific journal of clinical oncology
|April 16, 2025
概括
铁,一种由铁和脂质过氧化驱动的细胞死亡形式,在疾病中至关重要. 了解其调节是开发向癌症治疗的关键.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 铁亡是一种受调节的细胞死亡途径,其特征是铁过载和脂质过氧化物积累.
- 它不同于其他细胞死亡类型,如亡和热亡,涉及铁代谢,氨酸过氧化酶和脂质过氧化之间的复杂相互作用.
- 这些路径的干扰导致抗氧化能力降低和细胞损伤,导致疾病的发展.
研究的目的:
- 阐明铁灭症背后的分子机制.
- 探索铁质在癌症进展和治疗耐药性中的作用.
- 突出了解铁灭症对于向治疗的发展的重要性.
主要方法:
- 审查现有的关于铁亡的文献.
- 对ferroptosis生物化学和形态特征的分析.
- 研究铁代谢,谷氨和活性氧物种 (ROS) 之间的相互作用.
主要成果:
- 铁亡是由铁代谢失衡和抗氧化能力下降引起的,特别是涉及谷氨过氧化酶4 (GPX4).
- 这一过程导致有毒的脂质过氧化物和活性氧物种 (ROS) 的积累.
- 在瘤细胞中,铁亡调节器会影响扩散,抑制细胞亡,转移和耐药性,影响癌症的进展.
结论:
- 铁亡是关键调节的细胞死亡途径,涉及各种疾病,包括癌症.
- 向铁化提供了一个有前途的治疗策略,用于管理具有氧化应激和脂质过氧化特征的疾病.
- 进一步了解铁亡调节网络对于在瘤学中推进精准医学至关重要.
相关概念视频
Necrosis
3.7K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.7K
Overview of Cell Death
5.6K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
5.6K
Autophagic Cell Death
2.7K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Apoptosis
10.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
10.0K
The Extrinsic Apoptotic Pathway
5.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K


